SCHEMBL30108026

SCHEMBL30108026

COc1ccc(Nc2cc(Cl)nc(Cl)n2)c([N+](=O)[O-])c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 4/20 0.51
AKR1C2 P52895 4/20 0.51
KCNMA1 Q12791 1/20 0.49
MAPT P10636 7/20 0.49
MAPK1 P28482 2/20 0.49
ALDH1A1 P00352 2/20 0.49
TDP1 Q9NUW8 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
AKR1B10 O60218 1/20 0.48
AKR1B1 P15121 1/20 0.48
AKR1C4 P17516 1/20 0.48
AKR1C1 Q04828 1/20 0.48
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
PKM P14618 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30459933 0.84 AKR1C3 (0.50) AKR1C3AKR1C2KCNMA1MAPTMAPK1
SCHEMBL17683159 0.84 AKR1C3 (0.50) AKR1C3AKR1C2KCNMA1MAPTMAPK1
SCHEMBL6176751 0.84 GAA (0.59) AKR1C3AKR1C2KCNMA1MAPTMAPK1
SCHEMBL30108025 0.80 AKR1C3 (0.42) AKR1C3AKR1C2KCNMA1MAPTMAPK1
SCHEMBL30108000 0.78 MAPT (0.53) MAPTMAPK1ALDH1A1TDP1L3MBTL1
SCHEMBL4575162 0.76 AKR1C3 (0.70) AKR1C3AKR1C2MAPTMAPK1ALDH1A1
SCHEMBL430629 0.75 MAPT (0.59) AKR1C3AKR1C2MAPTMAPK1ALDH1A1
SCHEMBL31220866 0.75 MEN1 (0.68) AKR1C3AKR1C2KCNMA1MAPTMAPK1
SCHEMBL6705974 0.75 NPC1 (0.70) MAPTMAPK1ALDH1A1L3MBTL1NPC1
SCHEMBL6178670 0.74 ALDH1A1 (0.57) AKR1C3AKR1C2KCNMA1MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022203399-A1 ADENOSINE A2A RECEPTOR ANTAGONIST AND USE THEREOF 주식회사 스탠다임 2022-09-29 WO disclosed